Bioprocess Technology Market Size, Share, Growth and Global Analysis by Demand, Opportunity, Key Players and Forecast 2023 To 2033


 The Bioprocess Technology Market is estimated to grow at a CAGR of 15.1% from 2017 to 2023, when it is expected to reach US$ 25.9 billion. By the end of 2033, it is anticipated to produce US$106.1 billion in revenue.

The global Bioprocess Technology Market is anticipated to register an opulent growth opportunity with an exceptional CAGR of 15.2% during the forecast period from 2021 to 2031. The global bioprocess technology market was valued at US$ 17.3 Bn in 2020 and is projected to generate a revenue of US$ 81.2 Bn by the end of 2031. The growth of the market is attributed to the widespread consumer awareness regarding bioprocess technology on the rise and companies focusing on the launch of next-generation bioprocess products and engaging synergistic approaches for distribution and manufacturing through various market consolidation activities. 

According to the analysis conducted by Future Market Insights (FMI), the global bioprocess technology market was valued at US$ 17.3 Bn in 2020. The surging focus on alternative medicines and preventive measures combined with ongoing advances in bioprocess technology is driving current sales figures. Increasing expansions and product launches within emerging markets are driving growth in the market. The prominent market players are focusing on the expansion of their manufacturing capabilities with high flexibility and rapid operations. Key market players are also emphasizing the development and launch of next-generation bioprocess products. This is anticipated to not only work favorably for sales of bioprocess technology but also auger the growth in the overall fermentation technology market.     

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-13890

The present bioprocess product-development pipeline supports an outlook of continued healthy growth. The prominent bioprocess technology and bioprocess analyzer market players are concentrating on new product launches and implementing advanced technology to their present products. Future Market Insights expects the global bioprocess technology market to grow at a CAGR of 15.2% over the forecast period by 2031-end.

Key Takeaways

  • The major factor attributing to the preference for the single-use (disposable) bioreactor in the bioprocess industry is the production of different biopharmaceutical therapeutics, using the same facility, in minimum time and with minimum cost.
  • The increasing demand for personalized treatment for diseases like cancer is predicted to surge the demand for bioprocess therapies like cell therapy. The reduced cost of genetic sequencing shortly has enabled the production of personalized treatment plants and targeted therapies which are proven to be more effective than less-specific therapies as they ensure to divert their focus on a patient’s genetic and molecular makeup.
  • Technologically advanced techniques for process intensification are also being drastically applied to biosimilar manufacturing. The increasing usage of biosimilars in developed countries of Europe and the United States is anticipated to bolster the speed of the bioprocess technology adoption for rapid production of biosimilars.
  • Favorable government policies for various start-up companies specifically in developing countries are anticipated to create impressive opportunities for the market players in order to invest in the bioprocess technology market.
  • Mergers and acquisitions along with the expansion of manufacturing facilities all over the world are expected to bode well for the market across the projection period. Introducing advanced bioprocess products in order to leverage untapped market opportunities will remain a prominent growth driver over the forthcoming years.

Competitive Landscape

The bioprocess technology market players are predominantly aiming at strategic expansions in order to consolidate growth in the competitive market. The higher the demand for bioprocesses products, the stronger the pipeline, which is anticipated to lead to a phenomenal increase in demand over the global market. Major industry players are focusing on the launch of next generation biotherapeutics to treat serious life-threatening diseases.

More Insights into the Bioprocess Technology Market

In 2021, the U.S. was estimated to account for the maximum revenue of the total market share in the North American region over 89.6%. The dominance of the North American region continues to bestow over the forecast period driven by increasing requirements of upstream equipment. Increased living standards, health consciousness, and increasing disposable incomes are boosting the demand for effective treatments with minimal side effects. 

The U.K. market is predicted to exhibit around 12.4% CAGR over the assessment period owing to the use of single-use technologies, personalized treatment of rare diseases, and increased use of biosimilars had led to the rise in the demand for bioprocess technology.

The Indian bioprocess technology market is predicted to surge at an opulent CAGR of 18.6% during the forecast period. It has been anticipated to account for a market share of approximately 52.4% in the South Asian region. Primary factors supporting the growth of India's bioprocess technology market comprise the production of biopharmaceuticals like recombinant proteins and vaccines.

Key Players

  • Thermo Fisher Scientific Inc
  • Sartorius
  • Merck Kga
  • Danaher Corporation (Pall Biotech and Cytiva)
  • Merck KgaA
  • STADA Arzneimittel AG
  • Danaher Corporation
  • Applikon Biotechnology B.V. (Getinge)
  • Lonza AG, Bio-Rad Laboratories
  • Agilent technologies
  • Solida Biotech GmBH
  • Waters Corporation

Bioprocess Technology Market by Category

Product:

  • Upstream Equipment
    • Cell culture development products
      • Cell line development products
      • Cell Lines
      • Media, Sera, and other additives
      • Cell line development kits
  • Lab-scale Bioreactors
    • Continuous Stirred Tank Bioreactors
    • Bubble Column Bioreactors
    • Airlift Bioreactors
    • Fluidized Bed Bioreactors
    • Packed Bed Bioreactors
    • Photo-Bioreactors
  • Scale-up and production products
    • Cell culture media and feeds
    • BioProcess Containers & Fluid Transfer Solutions
      • Single-use
      • Reusable
  • BioReactors
    • Single-Use Bioprocess Equipment
    • Continuous Bioprocess Equipment
    • Real-Time Bioprocess Equipment
  • Harvest and collection
    • Harvest and separation products
    • Centrifuges for bioprocessing
    • Storage & Transport Products
    • v. Production Tanks and Drums
    • v. Outer Support Containers
  • Testing Products
    • Cell Counters & Viability Analysis Systems
    • Contamination & impurity testing products
  • Probes and Accessories
  • Downstream Equipment
    • Downstream purification
      • Chromatography Instruments
      • Chromatography Columns
      • Others (Resins and accessories)
    • Buffer preparation and supply
      • Reagents
      • mixing systems
  • Process analytical testing
    • Host cell residual DNA quantitation
    • Protein quantitation
    • Microbial identification
    • Others
  • Probes and Accessories

End-User:

  • Biotech / Biopharmaceutical Companies
  • CDMO / Contract Research Organization
  • Research / Academic Institutes

Comments

Post a Comment

Popular posts from this blog

Beyond COVID-19: A Look at Vaccines Market Post-Pandemic From 2023 to 2033

Image
 In recent years, the Vaccines Market has undergone a dramatic transition brought on by ground-breaking scientific discoveries and the pressing need for universal immunisation. The COVID-19 pandemic acted as a stimulus for a surge in vaccine demand that has prompted academics and pharmaceutical corporations to develop at a previously unheard-of rate. This blog examines the changing market environment for vaccines, highlighting significant trends, difficulties, and opportunities. Technology advancements like mRNA and vector-based platforms have completely changed how vaccines are developed. These innovative techniques have proven to be remarkably effective against contagious illnesses like COVID-19, opening the door for the development of new vaccines. In response to the pandemic, mRNA vaccines were developed and distributed quickly, showcasing the promise of these ground-breaking technology. Supercharge Your Knowledge: Dive into the Booming Vaccines market with Our Sample Report @ ht
Read more

Key Players Shaping the 3D Cell Culture Market: By 2022 to 2031

Image
  The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Billion in 2022 and attain a valuation of US$ 2.67 Billion by 2031. According to the analysis done by Future Market Insights, the global 3D cell culture market accounted for a CAGR of 4.8% in 2021. During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%. According to the studies conducted by Future Market Insights, the comparative analysis along with the market growth rate of the global 3D cell culture market is expected to show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS). The global 3D cell culture market observes a drop in the BPS values owned to its disadvantage as compared to surface
Read more

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more